Received: 14 May 2019
Accepted: 15 August 2019
First Online: 11 September 2019
Compliance with Ethical Standards
: This study was approved by an institutional review board at University of Southern California.
: Goldman is a consultant to Precision Health Economics, a healthcare consultancy providing services to the life sciences industry, and owns equity (< 1%) in its parent company, Precision Medicine Group. Myerson reports grant funding from Bristol-Myers Squibb for investigator-initiated research. Romley is a consultant to Precision Health Economics. Chiou, Tsugawa, and Kahn report nothing to disclose. These relationships did not impact the design, execution, or interpretation of this study.
Free to read: This content has been made available to all.